60 DEGREES PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (SXTP)

Q: What does CUSIP 83006G401 represent in this 13F holders report?

CUSIP 83006G401 is the security identifier for SXTP - 60 DEGREES PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held SXTP - 60 DEGREES PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share in Q3 2025?

7 institutional investors reported SXTP - 60 DEGREES PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share for Q3 2025. Use the holders table for investor-level position and value details.

CUSIP: 83006G401

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 4,285,676
Total 13F shares: 42,595
Share change: +27,354
Total reported value: $62,905
Price per share: $1.47
Number of holders: 7
Value change: +$40,482
Number of buys: 5
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 83006G401?
CUSIP 83006G401 identifies SXTP - 60 DEGREES PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2025
Previous quarter: Q2 2025

Recent filing periods for CUSIP 83006G401:

Q4 2025 Q3 2025 Q2 2025 Q1 2025

Top shareholders of SXTP - 60 DEGREES PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Knight Therapeutics Inc	3/4/5	Former 10% Owner	— mixed-class rows	1,232,700 mixed-class rows	$5,475,241	—	28 Jul 2023	3/4/5
CVI Investments, Inc.	13D/G	—	9.9%	455,545	$670,061	+$187,456	30 Sep 2025	13D/G
INTRACOASTAL CAPITAL, LLC	13D/G	Mitchell P. Kopin	10%	455,545	$587,653	+$107,220	30 Sep 2025	13D/G
Orca Capital AG	13D/G	—	4.9%	166,229	$382,327	$0	15 Jul 2025	13D/G
Ayrton Capital LLC	13D/G	—	4.1%	177,427	$260,977	+$20,515	30 Sep 2025	13D/G
ARMISTICE CAPITAL, LLC	13D/G	—	5%	77,357	$226,656	$0	31 Mar 2025	13D/G
KENTUCKY TECHNOLOGY INC.	3/4/5	10%+ Owner	— class O/S missing	525,000	$196,875	—	11 Jul 2023	3/4/5
Florida State University Research Foundation Inc.	3/4/5	10%+ Owner	— class O/S missing	405,000	$151,875	—	11 Jul 2023	3/4/5
Cheryl Xu	3/4/5	Director	0.37%	15,816	$45,866	+$14,410	03 Jun 2025	3/4/5
Tyrone Miller	3/4/5	CFO	— mixed-class rows	101,370 mixed-class rows	$38,237	—	17 Jan 2025	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.29%	12,516	$29,662	—	30 Jun 2025	13F
Walleye Capital LLC	13F	Company	— class O/S missing	222,906	$12,572	—	30 Jun 2025	13F
Kristen Landon	3/4/5	Chief Operating Officer	— mixed-class rows	8,707 mixed-class rows	$11,713	—	17 Jan 2025	3/4/5
CLEAR STREET LLC	13F	Company	— class O/S missing	145,987	$8,234	—	30 Jun 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	0.06%	2,598	$6,157	—	30 Jun 2025	13F
Charles W. Allen	3/4/5	Director	— mixed-class rows	18,000 mixed-class rows	$4,622	—	31 Dec 2023	3/4/5
Paul Field	3/4/5	Director	— mixed-class rows	18,000 mixed-class rows	$4,014	—	31 Dec 2023	3/4/5
Stephen Toovey	3/4/5	Director	— mixed-class rows	18,000 mixed-class rows	$4,014	—	31 Dec 2023	3/4/5
TORNO CAPITAL, LLC	13F	Company	— class O/S missing	47,169	$2,660	—	30 Jun 2025	13F
CITADEL ADVISORS LLC	13F	Company	— class O/S missing	17,668	$783	—	30 Jun 2025	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	100	$237	—	30 Jun 2025	13F
UBS Group AG	13F	Company	— mixed-class rows	1,515 mixed-class rows	$95	—	30 Jun 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	13	$30	—	30 Jun 2025	13F

Institutional Holders of 60 DEGREES PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (SXTP) as of Q3 2025

As of 30 Sep 2025, 60 DEGREES PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (SXTP) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,595 shares. The largest 7 holders included DRW Securities, LLC, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), UBS Group AG, CITIGROUP INC, OSAIC HOLDINGS, INC., and BANK OF AMERICA CORP /DE/. This page lists 7 institutional shareholders reporting positions in this security for the Q3 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

Q3 2025 holders

Holder diff

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 Value $	Q3 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.